About Sofinnova
Sofinnova is a Financial Services company. Biotech funding, drug development support, and investment in life sciences. It operates in the Financial Services and Healthcare sectors. Sofinnova offers products and services including Venture Capital Services and Partnership Support. Its focus areas include Finance, Investment, Life Sciences Funding and Capital Deployment.
Company details
Sofinnova is known for its role in funding over 115 transformative biotechs, with investments leading to 53 IPOs and 31 FDA-approved drugs. Experience spanning 120 years in operations and 100 years in investing is utilized to partner with entrepreneurs in advancing medical innovations. Guidance is provided through drug development, regulatory processes, and company building, challenging the status quo of healthcare and improving lives through collaborative efforts in life sciences.
- SectorsFinancial ServicesHealthcare
- Email••••••••
- Website sofinnova.com
- Legal Name Sofinnova
Products & Services of Sofinnova
Sofinnova offers a comprehensive portfolio of products and services, including Venture Capital Services and Partnership Support.
Funding and guidance are offered in drug development and biotech innovation to support company growth
Assistance is provided through regulatory processes and IPO preparation for life science ventures
People of Sofinnova
33 people are tracked at Sofinnova (14 in leadership, 19 in team).
| Name | Role | Group |
|---|---|---|
Eric Delbridge | General Partner, Public Equity | Leadership |
James Brody | Chief Compliance Officer & COO, Public Equity | Leadership |
David Kabakoff | Executive Partner, Private Equity | Leadership |
Debbie Murray | Chief People Officer | Leadership |
James Healy | Managing Partner | Leadership |
Jonathan Leff | Executive Partner, Private Equity | Leadership |
Perry Nisen | Executive Partner, Private Equity | Leadership |
Chris Carpenter | Executive Partner, Private Equity | Leadership |
Nathalie Auber | Partner & CFO | Leadership |
Hooman Shahlavi | Partner & Chief Legal Officer | Leadership |
Aneal Tenjarla | Partner & Associate Portfolio Manager, Public Equity | Leadership |
Jakob Dupont | Executive Partner, Private Equity | Leadership |
Katrin Viller | VP, Finance | Leadership |
Tiffany Davis | Director of IR & Marketing, Public Equity | Leadership |
Troy Ignelzi | Advisor | Team |
Steve Bilawey | IR & Marketing, Public Equity | Team |
Alex Chan | Controller, Private Equity | Team |
Vikrant Sangar | Controller, Public Equity | Team |
Alex Dulnev | IT Manager | Team |
Gina Baker | Compliance & Operations Manager, Public Equity | Team |
13 more people are available in the full profile.
Complete people profiles for Sofinnova
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of Sofinnova
Websites that share an audience with Sofinnova (sofinnova.com).
Websites whose visitors overlap most with Sofinnova. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| inva.com | 100% | 6.2K | View details | ||
| orbimed.com | 76% | 30.6K | #933,486 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sofinnova
Complete news archive for Sofinnova
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sofinnova
Sofinnova is known for its role in funding over 115 transformative biotechs, with investments leading to 53 IPOs and 31 FDA-approved drugs. Experience spanning 120 years in operations and 100 years in investing is utilized to partner with entrepreneurs in advancing medical innovations. Guidance is provided through drug development, regulatory processes, and company building, challenging the status quo of healthcare and improving lives through collaborative efforts in life sciences.
Sofinnova offers Venture Capital Services and Partnership Support.
Sofinnova operates through Sofinnova.